Wearable Devices (WLDS) CFO discloses initial share, option and RSU holdings

Rhea-AI Filing Summary

Wearable Devices Ltd. Chief Financial Officer Mualem Alon filed an initial Form 3 reporting his existing equity position. He directly holds 52,083 Ordinary Shares and has stock options covering 417 shares at an exercise price of $0.7200 expiring on January 23, 2032 and 83 shares at $316.8000 expiring on November 30, 2033. Footnotes also describe RSU awards for 5,000 Ordinary Shares vesting monthly through September 10, 2026 and 37,778 Ordinary Shares vesting monthly through January 1, 2029, each RSU representing one Ordinary Share.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mualem Alon

(Last) (First) (Middle)

5 HA-TNUFA STREET

(Street)

YOKNE'AM ILLIT 2066736

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Wearable Devices Ltd. [ WLDS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	52,083(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	01/23/2023	01/23/2032	Ordinary Shares	417(2)	$0.72	D
Stock option (right to buy)	08/23/2024	11/30/2033	Ordinary Shares	83(3)	$316.8	D

Explanation of Responses:

1. Includes (i) 5,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in equal monthly installments of 833 Ordinary Shares through September 10, 2026; and (ii) 37,778 Ordinary Shares issuable upon the vesting of RSUs in equal monthly installments of 1,111 Ordinary Shares through January 1, 2029. Each RSU represents the right to receive one Ordinary Share.

2. The options were granted on January 23, 2022 and vest as follows: 139 options vest on the first year anniversary of the grant date and the remaining 278 options vest in equal monthly installments of 12 Ordinary Shares after the first anniversary.

3. The options were granted on August 23, 2023 and vest as follows: 28 options vest on the first year anniversary of the grant date and the remaining 55 options vest in equal monthly installments of 2 Ordinary Shares after the first anniversary.

	/s/ Alon Mualem	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Wearable Devices (WLDS) CFO Mualem Alon report on this Form 3?

CFO Mualem Alon reports his existing equity stake in Wearable Devices. He directly holds 52,083 Ordinary Shares and has stock options and RSU awards that could deliver additional Ordinary Shares over time, reflecting his long-term, equity-based compensation structure with the company.

How many Wearable Devices (WLDS) shares does the CFO directly own?

The CFO directly owns 52,083 Ordinary Shares of Wearable Devices. This figure represents his beneficial ownership of the company’s common equity as of the Form 3 filing date, separate from additional shares that may be received through stock options or restricted share units in the future.

What stock options are disclosed for the Wearable Devices (WLDS) CFO?

The Form 3 shows two stock option positions for the CFO. One covers 417 Ordinary Shares at an exercise price of $0.7200 expiring January 23, 2032, and another covers 83 Ordinary Shares at $316.8000 expiring November 30, 2033, both held directly.

What RSU awards does the Wearable Devices (WLDS) CFO have?

Footnotes describe two RSU grants to the CFO. One represents 5,000 Ordinary Shares vesting in equal monthly installments of 833 shares through September 10, 2026, and another represents 37,778 Ordinary Shares vesting 1,111 shares monthly through January 1, 2029, each RSU delivering one Ordinary Share.

Does this Wearable Devices (WLDS) Form 3 show any insider buying or selling?

The Form 3 does not show new insider buying or selling activity. It is an initial statement of beneficial ownership listing existing Ordinary Shares, stock options, and RSU grants held by the CFO, rather than reporting open-market purchases or sales of the company’s stock.

What are the vesting terms of the Wearable Devices (WLDS) CFO stock options?

Footnotes explain the option vesting schedules. For the January 23, 2022 grant, 139 options vest on the first anniversary and the remaining 278 vest in monthly installments of 12 Ordinary Shares. For the August 23, 2023 grant, 28 options vest after one year and 55 vest monthly in 2-share increments.